quantisnow
FeedTopReportsPricing
⌘K
Live feed
09:00:00·127d
PRRelease
Salesforce Inc. logo
Novartis AG logo

Salesforce's Agentforce Life Sciences Selected by Novartis to Drive More Personalized Customer Engagement Globally

CRM· Salesforce Inc.NVS· Novartis AG
TechnologyHealth Care
Original source

Companies

  • CRM
    Salesforce Inc.
    Technology
  • NVS
    Novartis AG
    Health Care

Recent analyst ratings

  • Mar 11NVSUpdateArgus$180.00
  • Feb 26CRMUpdateBMO Capital Markets$225.00
  • Feb 20CRMUpdateBMO Capital Markets$235.00
  • Jan 27NVSUpdateCitigroup-
  • Jan 12CRMUpdateGoldman$330.00
  • Jan 6NVSUpdateBarclays-

Related

  • INSIDER13h
    Chief Eng/Cust Success Officer Tallapragada Srinivas converted options into 1,785 shares and covered exercise/tax liability with 14,667 shares, decreasing direct ownership by 16% to 68,477 units (SEC Form 4)
  • INSIDER13h
    Co-Founder and CTO, Slack Harris Parker converted options into 1,785 shares and covered exercise/tax liability with 14,667 shares, decreasing direct ownership by 7% to 161,109 units (SEC Form 4)
  • INSIDER13h
    Chair and CEO Benioff Marc covered exercise/tax liability with 22,560 shares (SEC Form 4)
  • PR1d
    Salesforce and Google Cloud Enable AI Agents to Act Across Both Platforms with Deep Context and End-to-End Workflows
  • SEC7d
    SEC Form DEFA14A filed by Salesforce Inc.
  • SEC7d
    SEC Form DEF 14A filed by Salesforce Inc.
  • PR8d
    Engine Powers Seamless Travel Experiences with Agentforce and Slack
  • SEC22d
    SEC Form S-8 filed by Salesforce Inc.
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022